Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:PRN NYSE:PTN NYSE:RENX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePRNInvesco Dorsey Wright Industrials Momentum ETF$162.44+0.2%$151.89$118.25▼$180.08$365.49M1.0744,477 shs17,635 shsPTNPalatin Technologies$0.09-44.6%$0.09$0.09▼$2.48$2.45M0.942.28 million shs14.57 million shsRENXRelx$21.19$0.00$20.06▼$23.30N/AN/A100,590 shs547,934 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePRNInvesco Dorsey Wright Industrials Momentum ETF+1.46%+3.88%+7.94%+22.74%+16.10%PTNPalatin Technologies0.00%0.00%0.00%-57.23%+9,409,900.00%RENXRelx0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationPRNInvesco Dorsey Wright Industrials Momentum ETFN/AN/AN/AN/AN/AN/AN/AN/APTNPalatin TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ARENXRelxN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePRNInvesco Dorsey Wright Industrials Momentum ETF 2.65Moderate Buy$162.44N/APTNPalatin Technologies 0.00N/AN/AN/ARENXRelx 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPRNInvesco Dorsey Wright Industrials Momentum ETFN/AN/AN/AN/AN/AN/APTNPalatin Technologies$350K6.99N/AN/AN/A∞RENXRelxN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePRNInvesco Dorsey Wright Industrials Momentum ETFN/AN/A28.33∞N/AN/AN/AN/AN/APTNPalatin TechnologiesN/A-$1.55N/A∞N/AN/AN/AN/AN/ARENXRelxN/A$1.2217.37∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPRNInvesco Dorsey Wright Industrials Momentum ETF$0.570.35%N/AN/AN/APTNPalatin TechnologiesN/AN/AN/AN/AN/ARENXRelx$0.281.32%N/A22.95%N/ALatest PRN, RENX, PTN, and OSL DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/23/2025PRNInvesco Dorsey Wright Industrials Momentum ETFQuarterly$0.07180.19%6/23/20256/23/20256/27/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPRNInvesco Dorsey Wright Industrials Momentum ETFN/APTNPalatin Technologies11.50%RENXRelx1.37%Insider OwnershipCompanyInsider OwnershipPRNInvesco Dorsey Wright Industrials Momentum ETFN/APTNPalatin Technologies7.10%RENXRelxN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePRNInvesco Dorsey Wright Industrials Momentum ETFN/A2.25 millionN/AOptionablePTNPalatin Technologies3026.01 millionN/AN/ARENXRelxN/AN/AN/ANot OptionablePRN, RENX, PTN, and OSL HeadlinesRecent News About These CompaniesHow Rex Harrison Was Upstaged By 1,200 Live Animals on Set of 1967 Musical ‘Doctor Doolittle’2 hours ago | yahoo.comNASCAR Hall of Famer Rex White dies at 952 hours ago | msn.comNASCAR Cup champion and Hall of Famer Rex White passes away2 hours ago | msn.comRex White, NASCAR Hall of Famer and 1960 Cup Series champion, dies at 952 hours ago | cbssports.comRex White, NASCAR pioneer and Hall of Famer, dies at 952 hours ago | msn.comForget Garmin, Amazon’s Choice Amazfit T-Rex 3 Outdoor Smartwatch Hits Its Lowest Price Since LaunchJuly 18 at 1:37 PM | gizmodo.comGThis rugged smartwatch is built for the outdoors — score the Amazfit T-Rex 3 for its best-ever priceJuly 18 at 8:36 AM | mashable.comMBeyond The Stands (Rex Baseball Celebrates History)July 18 at 3:31 AM | msn.comRex fall to Champion City, 2-0July 18 at 3:31 AM | msn.comRex add new logo to brandJuly 18 at 3:31 AM | sports.yahoo.comK-9 Rex joins Springfield Township Police DepartmentJuly 17 at 6:33 AM | msn.comAccused Gilgo Beach serial killer Rex Heuermann set for hearing to resume over DNA evidenceJuly 17 at 6:33 AM | newsday.comNRex Masai: Police officer who claimed to be off-duty cornered as IPOA unleashes photographic evidenceJuly 17 at 6:33 AM | msn.comRex pick up ninth-straight win, 5-3July 16 at 11:46 PM | msn.comRex’s Morning Forecast - 7/16July 16 at 6:44 PM | wdam.comWRex postponed Tuesday nightJuly 16 at 6:44 PM | sports.yahoo.comRex’s Midday Forecast - 7/16July 16 at 6:44 PM | wdam.comWThe T Rex Came Alive Filming Jurassic ParkJuly 16 at 6:44 PM | msn.comRex Salisbury’s Cambrian Ventures raises new fund, bucking fintech slowdownJuly 16 at 6:44 PM | msn.comRex’s Morning Forecast - 7/15July 15 at 7:01 PM | wdam.comWNew MarketBeat Followers Over TimeMedia Sentiment Over TimePRN, RENX, PTN, and OSL Company DescriptionsInvesco Dorsey Wright Industrials Momentum ETF NASDAQ:PRN$162.44 +0.30 (+0.19%) Closing price 03:59 PM EasternExtended Trading$162.43 -0.01 (-0.01%) As of 04:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PowerShares Dynamic Industrials Sector Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of the Dynamic Industrials Sector Intellidex Index (the Index). The Index consists of stocks of 60 United States industrial companies. These are companies that are principally engaged in the business of providing industrial products and services, including engineering, heavy machinery, construction, electrical equipment, aerospace and defense, and general manufacturing. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.Palatin Technologies NYSE:PTN$0.09 -0.08 (-44.65%) As of 05/7/2025Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.Relx NYSE:RENXRELX NV, through its interest in RELX Group plc, provides information and analytics for professional and business customers across industries worldwide. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment offers information and analytics to institutions and professionals. The Risk & Business Analytics segment provides solutions and decision tools that combine public and industry specific content with technology and analytics to evaluate and predict risk, as well as enhance operational efficiency. The Legal segment offers legal, regulatory, and business information and analytics. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier NV and changed its name to RELX NV in June 2015. RELX NV was incorporated in 1880 and is headquartered in Amsterdam, the Netherlands. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.